Recent Updates
Recently added Catalysts
GOSS Neutral Sentiment

Current treatment patterns in pulmonary arterial hypertension (PAH): Real-world data from a contemporary U.S. Physician survey

Key Takeaway: The article discusses current treatment patterns for pulmonary arterial hypertension (PAH) based on a survey of U.S. physicians. It highlights the use of Seralutinib and its relevance in treating PAH and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The survey aims to provide insights into real-world treatment approaches.
Price reaction · baseline $0.9379 (2024-10-25T18:39:00.000Z) · hit during market hours · clean, no other GOSS news in the window
day 0 close · peak
+0.3%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+53%
120-day peak, hindsight
Typical move
5.9%
average across 2 past catalysts
Cash runway
~4 mo
High dilution risk
Lead asset
GB001
Phase 2 · Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Full Press Release Details

Current treatment patterns in pulmonary arterial hypertension (PAH): Real-world data from a contemporary U.S. Physician survey
• About Overview Team Management Board of Directors Collaboration Contact Locations Contact Form Sponsorship Disclosure
• Seralutinib About Seralutinib PAH PH-ILD Posters & Presentations
• Patients Overview Expanded Access
• Investors Overview News Events & Presentations Events Presentations Filings Governance Overview Committee Composition Management Board of Directors Stock Stock Quote & Chart Historical Price Lookup Investment Calculator Analyst Coverage Info FAQs Contact IR Email Alerts
• Careers & Culture Who We Are Open Positions
• Overview
• Team
• Management
• Board of Directors
• Collaboration
• Contact
• Locations
• Contact Form
• Sponsorship Disclosure
• About Seralutinib
• PAH
• PH-ILD
• Posters & Presentations
• Overview
• Expanded Access
• Overview
• News
• Events & Presentations Events Presentations
• Filings
• Governance Overview Committee Composition Management Board of Directors
• Stock Stock Quote & Chart Historical Price Lookup Investment Calculator Analyst Coverage
• Info FAQs Contact IR Email Alerts
• Events
• Presentations
• Overview
• Committee Composition
• Management
• Board of Directors
• Stock Quote & Chart
• Historical Price Lookup
• Investment Calculator
• Analyst Coverage
• FAQs
• Contact IR
• Email Alerts
• Who We Are
• Open Positions
Last updated: Oct 25, 2024